Hemostasis and Tissue Sealing Agents Market Share, Trends, Growth, Analysis and Forecast 2023-2030

The global hemostasis and tissue sealing agents market is anticipated to grow at a CAGR of 9.3% during the forecast period (2023-2030). The treatment of chronic diseases leads to in the patient undergoing surgery, which drive the market growth. Urological disorders, Hernia fixation, spinal injuries, diabetes, burns, and ophthalmic injuries and replacements, are a few chronic conditions requiring these products. According to the WHO, an estimated 180,000 deaths every year are caused by burns. The vast majority occur in low- and middle-income countries. In India, over 1 million people are moderately or severely burnt every year. Further, United Spinal Association, in July 2022, every year approximately 17,700 Americans acquire a spinal cord injury. Roughly 78% are men, and their average age is 43. Most spinal cord injuries happen because of a vehicle accident (39.3%), followed closely by falls (31.8%), trailed by violence (13.2%), sports (8%), and medical/surgery (4.3%). As per the American Academy of Ophthalmology Study 2023, a new study found that hospitalizations of people who had eye trauma rose by 18% over 13 years. Most of the increase was due to falls among people over age 65.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hemostasis-and-tissue-sealing-agents-market

Owing to these factors, the manufacturers are compelled to develop the products o cater the market growth. In December 2019, Johnson & Johnson Medical Devices Companies Ethicon, Inc., launched the VISTASEAL™ Fibrin Sealant (Human) to manage bleeding during surgery. VISTASEAL Fibrin Sealant (Human) contains a combination of fibrinogen and thrombin, clotting proteins found in human plasma. When applied to the bleeding site, it forms a rapid, adherent, and durable clot and has been demonstrated to sustain hemostasis, even in high-risk patients. In three randomized controlled trials, VISTASEAL was associated with a lower overall hemostatic retreatment rate (0.9%-7.8%) compared to standard treatments (8.0%-16.7%).

Market Coverage

• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Product
o By Material
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
Competitive Landscape- includes Baxter International, Inc., Becton, Dickinson & Co., Johnson & Johnson Medical NV, Medtronic Plc., Pfizer, Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Hemostasis and Tissue Sealing Agents Market Report Segment

By Product

• Topical Hemostat
• Adhesive and Tissue Sealant

By Material

• Collagen-based Topical Hemostats
• Gelatin based Topical Hemostats
• ORC-based Topical Hemostats
• Polysaccharide based Topical Hemostats

By Application

• General Surgery
• Minimally Invasive Surgery
• Trauma
• Other Applications (Hemophilia)

By End-User

• Hospitals
• Ambulatory Surgical Centers

A full report of Hemostasis and Tissue Sealing Agents Market available @ https://www.omrglobal.com/industry-reports/hemostasis-and-tissue-sealing-agents-market

Global Hemostasis and Tissue Sealing Agents Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

Company Profiles

• Advance Medical Solution Group Plc
• Artivion, Inc.,
• B Braun Holding GmbH & Co. KG
• Biomet Inc
• BioSpace, Inc.
• Cohera Medical Inc.,
• Covidien Plc
• Cryolife Inc.,
• Ethicon LLC
• Hyperbranch Medical Technology
• Integra Lifesciences Corp.,
• Issuu Inc.,

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.


Read Our Other More Reports@ https://www.linkedin.com/pulse/artificial-retina-market-share-trends-future-outlook-arti-vishwakarma-7xwsc

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.